ANAVEX LIFE SCIENCES CORP. Weighted Average Number of Shares Outstanding, Basic and Diluted
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 76.00 million shares for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-02-09
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 76.00M shares, a 18.20% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 68.59M shares, a 17.55% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 64.30M shares, a 17.38% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 60.58M shares, a 15.27% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 69.80M shares, a 19.95% increase from fiscal 2020.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 58.19M shares, a 18.99% increase from fiscal 2019.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 48.91M shares, a 9.52% increase from fiscal 2018.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 44.66M shares, a 9.34% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | 76.00M shares 10-Q · filed 2022-02-09 | ||||
| 2021-09-30 | 69.80M shares 10-K · filed 2021-11-24 | ||||
| 2021-03-31 | 68.59M shares 10-Q · filed 2021-05-13 | 66.42M shares 10-Q · filed 2021-05-13 | 64.49M shares derived: average of 3 quarters · filed 2022-02-09 | 63.14M shares derived: average of 4 quarters · filed 2022-02-09 | |
| 2020-12-31 | 64.30M shares 10-Q · filed 2022-02-09 | 62.44M shares derived: average of 2 quarters · filed 2022-02-09 | 61.33M shares derived: average of 3 quarters · filed 2022-02-09 | 60.58M shares derived: average of 4 quarters · filed 2022-02-09 | |
| 2020-09-30 | 60.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | 59.84M shares derived: average of 2 quarters · filed 2021-11-24 | 59.34M shares derived: average of 3 quarters · filed 2021-11-24 | 58.19M shares 10-K · filed 2021-11-24 | |
| 2020-06-30 | 59.11M shares 10-Q · filed 2020-08-06 | 58.73M shares derived: average of 2 quarters · filed 2021-05-13 | 57.40M shares 10-Q · filed 2020-08-06 | 56.20M shares derived: average of 4 quarters · filed 2021-05-13 | |
| 2020-03-31 | 58.35M shares 10-Q · filed 2021-05-13 | 56.54M shares 10-Q · filed 2021-05-13 | 56.55M shares 10-Q · filed 2020-05-07 | 55.23M shares derived: average of 3 quarters · filed 2021-05-13 | 53.83M shares derived: average of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | 54.77M shares 10-Q · filed 2021-02-16 | 53.66M shares derived: average of 2 quarters · filed 2021-02-16 | 52.32M shares derived: average of 3 quarters · filed 2021-02-16 | 51.02M shares derived: average of 4 quarters · filed 2021-02-16 | |
| 2019-09-30 | 52.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | 51.09M shares derived: average of 2 quarters · filed 2020-12-28 | 49.77M shares derived: average of 3 quarters · filed 2020-12-28 | 48.91M shares 10-K · filed 2020-12-28 | |
| 2019-06-30 | 49.62M shares 10-Q · filed 2020-08-06 | 48.38M shares derived: average of 2 quarters · filed 2020-08-06 | 47.69M shares 10-Q · filed 2020-08-06 | 47.15M shares derived: average of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | 47.13M shares 10-Q · filed 2020-05-07 | 46.73M shares 10-Q · filed 2020-05-07 | 46.33M shares derived: average of 3 quarters · filed 2020-05-07 | 46.05M shares derived: average of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | 46.33M shares 10-Q · filed 2020-02-06 | 45.93M shares derived: average of 2 quarters · filed 2020-02-06 | 45.69M shares derived: average of 3 quarters · filed 2020-02-06 | 45.40M shares derived: average of 4 quarters · filed 2020-02-06 | |
| 2018-09-30 | 45.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | 45.37M shares derived: average of 2 quarters · filed 2019-12-16 | 45.09M shares derived: average of 3 quarters · filed 2019-12-16 | 44.66M shares 10-K · filed 2019-12-16 | |
| 2018-06-30 | 45.21M shares 10-Q · filed 2019-08-07 | 44.88M shares derived: average of 2 quarters · filed 2019-08-07 | 44.37M shares 10-Q · filed 2019-08-07 | 43.99M shares derived: average of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | 44.55M shares 10-Q · filed 2019-05-09 | 44.21M shares 10-Q · filed 2019-05-09 | 43.59M shares derived: average of 3 quarters · filed 2019-05-09 | 43.07M shares derived: average of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | 43.88M shares 10-Q · filed 2019-02-07 | 43.11M shares derived: average of 2 quarters · filed 2019-02-07 | 42.57M shares derived: average of 3 quarters · filed 2019-02-07 | 42.22M shares derived: average of 4 quarters · filed 2019-02-07 | |
| 2017-09-30 | 42.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | 41.92M shares derived: average of 2 quarters · filed 2019-01-25 | 41.67M shares derived: average of 3 quarters · filed 2019-01-25 | 40.84M shares 10-K · filed 2019-01-25 | |
| 2017-06-30 | 41.51M shares 10-Q · filed 2018-08-09 | 41.33M shares derived: average of 2 quarters · filed 2018-08-09 | 40.34M shares 10-Q · filed 2018-08-09 | 39.20M shares derived: average of 4 quarters · filed 2019-01-25 | |
| 2017-03-31 | 41.16M shares 10-Q · filed 2018-05-10 | 39.76M shares 10-Q · filed 2018-05-10 | 38.43M shares derived: average of 3 quarters · filed 2019-01-25 | 37.75M shares derived: average of 4 quarters · filed 2019-01-25 | |
| 2016-12-31 | 38.39M shares 10-Q · filed 2018-02-07 | 37.06M shares derived: average of 2 quarters · filed 2019-01-25 | 36.61M shares derived: average of 3 quarters · filed 2019-01-25 | ||
| 2016-09-30 | 35.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | 35.72M shares derived: average of 2 quarters · filed 2019-01-25 | 35.15M shares 10-K · filed 2019-01-25 | ||
| 2016-06-30 | 35.71M shares 10-Q · filed 2017-08-07 | 34.96M shares 10-Q · filed 2017-08-07 | |||
| 2015-09-30 | 18.58M shares 10-K · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |